Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $4000.00 | Pages : 300 | Published : January 2022 | SKU CODE : r401 | Delivery Time: 2-3 business days | Format :


The central nervous system (CNS) drugs market consists of sales of central nervous system drugs and related services by entities (organizations, sole traders and partnerships) that manufacture central nervous system drugs that are used in the treatment of diseases affecting the brain or spinal cord. The central nervous system integrates sensory information and instructs the body to respond accordingly. The spinal cord is a channel for signals between the brain and the rest of the body. CNS disorder is a condition in which the brain and spinal cord’s ability to function is affected, hence affecting the body. The market for CNS disorder drugs comprises of drugs that work in different ways depending on the type of disease by suppressing or boosting the brain activities

The main types of central nervous system (CNS) drugs are analgesics, anti-parkinson drugs, anesthetics, anti-epileptics and other CNS drugs. Analgesics, also known as painkillers, are medications that alleviate various types of pain, ranging from headaches to injuries to arthritis. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others.

The global central nervous system drugs market size is expected to grow from $169.11 billion in 2021 to $178.70 billion in 2022 at a compound annual growth rate (CAGR) of 5.7%. The growth in the CNS drugs market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The central nervous system drugs market is expected to reach $264.97 billion in 2026 at a CAGR of 10.3%.

The central nervous system drugs market will be driven by rapid growth in emerging markets in the forecast period. Emerging markets growth is aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP growth rate was 2.3% in 2020., according to the World Economic Outlook Reports by the IMF, the global growth is 6% in 2021 and expected to be 4.4% in 2022. Thus, strong economic growth will boost the demand for central nervous system drugs and this will drive the market during the forecast period.

During the forecast period, the growth of the central nervous system drugs market will be restrained by patent expiration of branded central nervous system drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this will negatively impact the growth of the market in terms of value.

Many central nervous system drug manufacturers are collaborating with other manufacturers in the industry to share technical knowledge and improve product quality. These agreements are helping anti-epileptics drugs manufacturers broaden their products and services. For instance, in March 2021, SEQENS and Rondol Group had announced a collaboration in formulation research and continuous flow manufacturing for existing, repurposed, or new drugs for oncology, infectious diseases, and central nervous system disorders. In June 2021, DSM and Brains Bioceutical have established a global exclusive partnership to unlock the therapeutic potential of cannabinoids in early-stage drug development. The cannabinoid API market is rapidly expanding, fueled by strong scientific evidence demonstrating cannabinoid's potential in a variety of therapeutic areas, including Central Nervous System (CNS) diseases.

Major companies in the central nervous system drugs market include Biogen Inc, Johnson & Johnson, Novartis AG, UCB S.A., Takeda Pharmaceuticals, AbbVie, Teva Pharmaceuticals, GlaxosmithKline, Daiichi Sankyo Company and H Lundbeck.

North America was the largest region in the central nervous system drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the CNS drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the central nervous system drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global central nervous system drugs market is segmented -

1) By Type: Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    Table Of Contents

    1. Executive Summary

    2. Report Structure

    3. Central Nervous System Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Central Nervous System Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Central Nervous System Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Central Nervous System Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Central Nervous System Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Central Nervous System Drugs

    9. Central Nervous System Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Central Nervous System Drugs Market Regional Analysis

    10.1. Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)

    10.2. Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    10.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

    11. Central Nervous System Drugs Market Segmentation

    11.1. Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Analgesics

    Anti-Parkinson drugs

    Anesthetics

    Anti-Epileptics

    Other CNS drugs

    11.2. Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Central Nervous System Drugs Market Metrics

    12.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global

    12.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global

    13. Asia-Pacific Central Nervous System Drugs Market

    13.1. Asia-Pacific Central Nervous System Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Central Nervous System Drugs Market Metrics

    13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries

    13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries

    13.6. Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

    13.7.1. China Central Nervous System Drugs Market

    13.7.1.1. China Central Nervous System Drugs Market Overview

    13.7.1.2. China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.1.3. China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2. Australia Central Nervous System Drugs Market

    13.7.2.1. Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2.2. Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.3. Hong Kong Central Nervous System Drugs Market

    13.7.3.1. Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4. India Central Nervous System Drugs Market

    13.7.4.1. India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4.2. India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5. Indonesia Central Nervous System Drugs Market

    13.7.5.1. Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5.2. Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6. Japan Central Nervous System Drugs Market

    13.7.6.1. Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6.2. Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.7. Malaysia Central Nervous System Drugs Market

    13.7.7.1. Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.8. New Zealand Central Nervous System Drugs Market

    13.7.8.1. New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.9. Philippines Central Nervous System Drugs Market

    13.7.9.1. Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.10. Singapore Central Nervous System Drugs Market

    13.7.10.1. Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11. South Korea Central Nervous System Drugs Market

    13.7.11.1. South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11.2. South Korea Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.12. Thailand Central Nervous System Drugs Market

    13.7.12.1. Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.13. Vietnam Central Nervous System Drugs Market

    13.7.13.1. Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14. Western Europe Central Nervous System Drugs Market

    14.1. Western Europe Central Nervous System Drugs Market Overview

    14.2. Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    14.3. Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    14.4. Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Central Nervous System Drugs Market Metrics

    14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries

    14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries

    14.6. Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7. Western Europe Central Nervous System Drugs Market: Country Analysis

    14.7.1. Austria Central Nervous System Drugs Market

    14.7.1.1. Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.2. Belgium Central Nervous System Drugs Market

    14.7.2.1. Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.3. Denmark Central Nervous System Drugs Market

    14.7.3.1. Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.4. Finland Central Nervous System Drugs Market

    14.7.4.1. Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5. France Central Nervous System Drugs Market

    14.7.5.1. France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5.2. France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6. Germany Central Nervous System Drugs Market

    14.7.6.1. Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6.2. Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.7. Ireland Central Nervous System Drugs Market

    14.7.7.1. Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.8. Italy Central Nervous System Drugs Market

    14.7.8.1. Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.9. Netherlands Central Nervous System Drugs Market

    14.7.9.1. Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.10. Norway Central Nervous System Drugs Market

    14.7.10.1. Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.11. Portugal Central Nervous System Drugs Market

    14.7.11.1. Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.12. Spain Central Nervous System Drugs Market

    14.7.12.1. Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.13. Sweden Central Nervous System Drugs Market

    14.7.13.1. Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.14. Switzerland Central Nervous System Drugs Market

    14.7.14.1. Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15. UK Central Nervous System Drugs Market

    14.7.15.1. UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15.2. UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15. Eastern Europe Central Nervous System Drugs Market

    15.1. Eastern Europe Central Nervous System Drugs Market Overview

    15.2. Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    15.3. Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    15.4. Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Central Nervous System Drugs Market Metrics

    15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries

    15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries

    15.6. Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis

    15.7.1. Czech Republic Central Nervous System Drugs Market,  

    15.7.1.1. Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.2. Poland Central Nervous System Drugs Market

    15.7.2.1. Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.3. Romania Central Nervous System Drugs Market

    15.7.3.1. Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4. Russia Central Nervous System Drugs Market

    15.7.4.1. Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4.2. Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16. North America Central Nervous System Drugs Market

    16.1. North America Central Nervous System Drugs Market Overview

    16.2. North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    16.3. North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    16.4. North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    16.5. North America, Central Nervous System Drugs Market Metrics

    16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries

    16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries

    16.6. North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7. North America Central Nervous System Drugs Market: Country Analysis

    16.7.1. Canada Central Nervous System Drugs Market

    16.7.1.1. Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.2. Mexico Central Nervous System Drugs Market

    16.7.2.1. Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3. USA Central Nervous System Drugs Market

    16.7.3.1. USA Central Nervous System Drugs Market Overview

    16.7.3.2. USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3.3. USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17. South America Central Nervous System Drugs Market

    17.1. South America Central Nervous System Drugs Market Overview

    17.2. South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    17.3. South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    17.4. South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    17.5. South America, Central Nervous System Drugs Market Metrics

    17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries

    17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries

    17.6. South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7. South America Central Nervous System Drugs Market: Country Analysis

    17.7.1. Argentina Central Nervous System Drugs Market

    17.7.1.1. Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2. Brazil Central Nervous System Drugs Market

    17.7.1.1. Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2.2. Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.3. Chile Central Nervous System Drugs Market

    17.7.3.1. Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.4. Colombia Central Nervous System Drugs Market

    17.7.4.1. Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.5. Peru Central Nervous System Drugs Market

    17.7.5.1. Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.6. Venezuela Central Nervous System Drugs Market

    17.7.6.1. Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18. Middle East Central Nervous System Drugs Market

    18.1. Middle East Central Nervous System Drugs Market Overview

    18.2. Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    18.3. Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    18.4. Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Central Nervous System Drugs Market Metrics

    18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries

    18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries

    18.6. Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7. Middle East Central Nervous System Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Central Nervous System Drugs Market

    18.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.2. Israel Central Nervous System Drugs Market

    18.7.2.1. Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.3. Turkey Central Nervous System Drugs Market

    18.7.3.1. Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.4. UAE Central Nervous System Drugs Market

    18.7.4.1. UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19. Africa Central Nervous System Drugs Market

    19.1. Africa Central Nervous System Drugs Market Overview

    19.2. Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)

    19.3. Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    19.4. Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    19.5. Africa, Central Nervous System Drugs Market Metrics

    19.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries

    19.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries

    19.6. Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7. Africa Central Nervous System Drugs Market: Country Analysis

    19.7.1. Egypt Central Nervous System Drugs Market

    19.7.1.1. Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.2. Nigeria Central Nervous System Drugs Market

    19.7.2.1. Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.3. South Africa Central Nervous System Drugs Market

    19.7.3.1. South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    20. Central Nervous System Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Biogen Inc

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Johnson & Johnson

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Novartis AG

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. UCB S.A.

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Takeda Pharmaceuticals

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Central Nervous System Drugs Market In 2026- Growth Countries

    23.2. Global Central Nervous System Drugs Market In 2026- Growth Segments

    23.3. Global Central Nervous System Drugs Market In 2026- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4: Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12: Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
  • Table 13: Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
  • Table 18: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19: China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20: China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21: Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22: Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23: Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24: India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25: India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26: Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27: Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28: Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29: Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30: Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31: New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32: Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33: Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34: South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35: Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36: Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37: Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 38: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 39: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 41: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
  • Table 42: Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43: Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44: Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45: Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46: Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47: France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48: France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49: Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50: Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51: Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52: Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53: Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54: Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55: Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56: Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57: Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58: Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59: UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60: UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61: Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 65: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
  • Table 66: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67: Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68: Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69: Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70: Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71: Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72: North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 73: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 74: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
  • Table 76: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
  • Table 77: North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78: Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79: Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 80: USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 81: USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 82: South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 83: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 84: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
  • Table 86: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
  • Table 87: South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88: Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89: Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90: Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91: Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92: Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 93: Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 94: Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95: Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 96: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 97: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 99: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
  • Table 100: Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 101: Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102: Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103: Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104: UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105: Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 106: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 107: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
  • Table 109: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
  • Table 110: Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 111: Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 112: Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113: South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114: Biogen Inc Financial Performance
  • Table 115: Johnson & Johnson Financial Performance
  • Table 116: Novartis AG Financial Performance
  • Table 117: UCB S.A. Financial Performance
  • Table 118: Takeda Pharmaceuticals Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Central Nervous System Drugs Market In 2026- Growth Countries
  • Table 124: Global Central Nervous System Drugs Market In 2026- Growth Segments
  • Table 125: Global Central Nervous System Drugs Market In 2026- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4: Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12: Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
  • Figure 13: Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
  • Figure 18: Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19: China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20: China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21: Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22: Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23: Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24: India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25: India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26: Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27: Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28: Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29: Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30: Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31: New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32: Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33: Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34: South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35: Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36: Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37: Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 38: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 39: Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 40: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 41: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
  • Figure 42: Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43: Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44: Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45: Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46: Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47: France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48: France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49: Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50: Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51: Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52: Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53: Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54: Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55: Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56: Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57: Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58: Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59: UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60: UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61: Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 62: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 63: Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 64: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 65: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
  • Figure 66: Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67: Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68: Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69: Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70: Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71: Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72: North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 73: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 74: North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 75: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
  • Figure 76: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
  • Figure 77: North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78: Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79: Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 80: USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 81: USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 82: South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 83: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 84: South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 85: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
  • Figure 86: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
  • Figure 87: South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88: Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89: Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90: Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91: Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92: Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 93: Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 94: Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95: Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 96: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 97: Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 98: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 99: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
  • Figure 100: Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 101: Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102: Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103: Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104: UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105: Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 106: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 107: Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 108: Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 109: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
  • Figure 110: Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 111: Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 112: Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113: South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114: Biogen Inc Financial Performance
  • Figure 115: Johnson & Johnson Financial Performance
  • Figure 116: Novartis AG Financial Performance
  • Figure 117: UCB S.A. Financial Performance
  • Figure 118: Takeda Pharmaceuticals Financial Performance
  • Figure 119: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 121: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 122: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 123: Global Central Nervous System Drugs Market In 2026- Growth Countries
  • Figure 124: Global Central Nervous System Drugs Market In 2026- Growth Segments
  • Figure 125: Global Central Nervous System Drugs Market In 2026- Growth Strategies
Global Contract Research And Manufacturing Services (CRAMS) Market Size, Forecasts, And Opportunities – Includes CRAMS Market Overview
Global Pulmonary Arterial Hypertension Market Overview And Prospects – Includes Pulmonary Arterial Hypertension Market Share
Global Botanical Supplements Market Outlook, Opportunities And Strategies – Includes Botanical Supplements Industry
Global Pharmacovigilance Market Size, Forecasts, And Opportunities – Includes Pharmacovigilance Market Share
Global Herbal Supplements Market Outlook, Opportunities And Strategies – Includes Herbal Supplements Market Size
Global Hyperphosphatemia Treatment Market Outlook, Opportunities And Strategies – Including Hyperphosphatemia Treatment Algorithm
Global Multivitamin Capsules And Tablets Market Size, Forecasts, And Opportunities – Includes Vitamin Industry Trends
Global Naloxone Spray Market Overview And Prospects – Including pharmacies
Analgesics Global Market Report 2022 – By Type (Non-opioids, Opioids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), By Route of Administration (Oral, Intravenous, Rectal, Transdermal, Topical), By Drug Type (Prescription Analgesics, OTC Analgesics), By Application (Internal Analgesics, External Analgesics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Antiemetics And Antinauseants Global Market Report 2022 – By Drug (Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Others), By Application (Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others), By End Users (Hospital, Medical Center, Clinic, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Anti-Parkinson Drugs Global Market Report 2022 – By Drugs Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics), By Route of Administration (Oral, Injection, Transdermal), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Anesthetics Global Market Report 2022 – By Type (General Anesthetics, Local Anesthetics), By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications), By Route of Administration (Inhalation Anaesthesia Drugs, Intravenous Anaesthesia Drugs, Topical Anaesthesia Drugs), By Local Anesthetics(Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine, Other Local Anesthesia Drugs), By General Anesthetics(Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam, Other General Anesthesia Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Brain And Neuroimaging Devices Global Market Report 2022 – By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG)), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders), By End User (Hospitals, Diagnostic Centres, Ambulatory Surgical Centres) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Antibody Drug Conjugates Global Market Report 2022 – By Type (Monoclonal Antibodies, Linker, Drug/Toxin), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor), By Product (Adcertis, Kadcyla), By Technology (Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology), By End User (Hospital, Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Generic Pharmaceuticals Global Market Report 2022 – By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Inectables, Dermal/Topical, Inhaler) – Market Size, Trends, And Global Forecast 2022-2026
View Report